Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
EX-QNRF-ANMR-14: Development of Novel Multi-Specific Nanobodies Targeting Alpha-Synuclein Pathology as a Therapeutic Strategy for Parkinson's Disease and other Synucleinopathies
El-Agnaf, O. M. A. (Lead Principal Investigator), Mahmoud Mesleh, A. G. (Post Doctoral Fellow), Mazzocco, D. C. (Post Doctoral Fellow) & Bezard, D. E. (Principal Investigator)
1/03/26 → 1/03/28
Project: Experimental Development/Translation Research
-
EX-Silverstein -1: Therapeutic Nanobody Development for Targeting α-Synuclein Aggregation in Parkinson's Disease, with Focus on Parkinson's Disease with GBA Mutation
El-Agnaf, O. M. A. (Lead Principal Investigator) & Mahmoud Mesleh, A. G. (Post Doctoral Fellow)
1/01/24 → 1/01/26
Project: Experimental Development/Translation Research